{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:56:54Z","timestamp":1772456214181,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer (PC) is a highly prevalent and aggressive malignancy of the digestive system, characterized by notably low survival rates. Recently, the influence of gut microbiota (GM) on the development and progression of PC has gained more attention. While the only existing bibliometric study has explored the association of GM in PC, it has failed to adequately reflect the latest trends and hotspots in this field due to research timeframes and methodologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications from January 1, 2000 to November 18, 2023 were collected from the Web of Science Core Collection (WoSCC) and screened based on specific criteria. Various software tools, including VOSviewer, Scimago Graphica, R, Pajek64 and Cite Space, were employed in this bibliometric study to visualize research trends and hot spots concerning the relationship between GM and PC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study analyzed 763 publications, including 397 articles and 366 reviews, on the relationship between GM and PC. The number of Publications has steadily increased since 2013, with China and the USA leading in contribution. The journal\n                      <jats:italic>Cancers<\/jats:italic>\n                      published the most papers (37), while\n                      <jats:italic>Gut<\/jats:italic>\n                      had the highest average citations (136.83). The most productive institution was SUTMD Anderson Cancer Center, and the top 3 authors were Michaud, Dominique S. McAllister, Florencia, and Miller, George. Keyword analysis revealed that \u201cGut Microbiota\u201d, \u201cPancreatic Cancer\u201d, \u201cCancer\u201d, \u201cSequence\u201d, \u201cMicrobiome\u201d and \u201cTumor Microbiome\u201d are the most frequent terms, highlighting key research trends.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over the past two decades, interest in the relationship between GM and PC has significantly increased. The comprehensive bibliometric analysis offers an in-depth evaluation of the prevailing research trends and advancements regarding the relationship between GM and PC. It indicates that current research hotspots mainly focus on \u201csequencing\u201d, \u201cmicrobiomes\u201d and \u201ctumor microbiomes\u201d.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1623945","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:01:41Z","timestamp":1772452901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bibliometric analysis of the trends in research on the link between gut microbiota and pancreatic cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhimin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhantao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14297","DOI":"10.1007\/s00432-023-05245-5","article-title":"Pancreatic cancer: experience from an emerging country in North Africa","volume":"149","author":"Amri","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.pan.2022.05.005","article-title":"Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines","volume":"22","author":"Bennett","year":"2022","journal-title":"Pancreatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1137576","article-title":"Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/03936155231166721","article-title":"Alterations of commensal microbiota are associated with pancreatic cancer","volume":"38","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Markers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15234","article-title":"Diabetes and pancreatic cancer risk in a multiracial cohort","volume":"41","author":"Conway","year":"2024","journal-title":"Diabetes Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/frmbi.2025.1543144","article-title":"Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans","volume":"4","author":"da Cruz","year":"2025","journal-title":"Front. Microbiomes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"188484","DOI":"10.1016\/j.bbcan.2020.188484","article-title":"Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer","volume":"1875","author":"Dong","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jambio\/lxad221","article-title":"Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives","volume":"134","author":"Feng","year":"2023","journal-title":"J. Appl. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101361","DOI":"10.1016\/j.cpcardiol.2022.101361","article-title":"Frontiers and hotspots evolution in psycho-cardiology: A bibliometric analysis from 2004 to 2022","volume":"47","author":"Ge","year":"2022","journal-title":"Curr. Probl Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/00365521.2022.2114812","article-title":"Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result","volume":"58","author":"Hashimoto","year":"2023","journal-title":"Scand. J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19759","article-title":"A bibliometric analysis of programmed cell death in acute lung injury\/acute respiratory distress syndrome from 2000 to 2022","volume":"9","author":"Huang","year":"2023","journal-title":"Heliyon"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43640","DOI":"10.1038\/srep43640","article-title":"Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities","volume":"7","author":"Jandhyala","year":"2017","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1096806","article-title":"Immune-related adverse events: A bibliometric analysis","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","article-title":"A faecal microbiota signature with high specificity for pancreatic cancer","volume":"71","author":"Kartal","year":"2022","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","article-title":"Burden of pancreatic cancer: from epidemiology to practice","volume":"19","author":"Khalaf","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3892\/ijo.2020.5096","article-title":"Probiotic\u2212derived ferrichrome inhibits the growth of refractory pancreatic cancer cells","volume":"57","author":"Kita","year":"2020","journal-title":"Int. J. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.outlook.2021.02.006","article-title":"Meta approaches in knowledge synthesis in nursing: A bibliometric analysis","volume":"69","author":"Kokol","year":"2021","journal-title":"Nurs. Outlook"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1038\/s41598-021-90707-4","article-title":"Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway","volume":"11","author":"Konishi","year":"2021","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.928846","article-title":"An Exploration of Oral-Gut Pathogens Mediating Immune Escape of Pancreatic Cancer via miR-21\/PTEN Axis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/mi.2008.5","article-title":"Mucins in the mucosal barrier to infection","volume":"1","author":"Linden","year":"2008","journal-title":"Mucosal Immunol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1159707","article-title":"Integrated 16S rRNA sequencing and nontargeted metabolomics analysis to reveal the mechanisms of Yu-Ye Tang on type 2 diabetes mellitus rats","volume":"14","author":"Ma","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrmicro2538","article-title":"Mucin dynamics and enteric pathogens","volume":"9","author":"McGuckin","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm12134318","article-title":"Modifiable pancreatic ductal adenocarcinoma (PDAC) risk factors","volume":"12","author":"Michalak","year":"2023","journal-title":"J. Clin. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"106720","DOI":"10.1016\/j.aap.2022.106720","article-title":"Macro-level literature analysis on pedestrian safety: Bibliometric overview, conceptual frames, and trends","volume":"174","author":"Mirhashemi","year":"2022","journal-title":"Accid Anal. Prev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.18632\/oncotarget.3109","article-title":"Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"B31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"101039","DOI":"10.1016\/j.xcrm.2023.101039","article-title":"From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer","volume":"4","author":"Seo","year":"2023","journal-title":"Cell Rep. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.907851","article-title":"Schizophrenia and inflammation research: A bibliometric analysis","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1038\/s41598-021-90024-w","article-title":"The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes","volume":"11","author":"Talukdar","year":"2021","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","article-title":"Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models","volume":"39","author":"Thomas","year":"2018","journal-title":"Carcinogenesis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1281451","article-title":"Bibliometric analysis of global research trends between gut microbiota and pancreatic cancer: from 2004 to 2023","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2112881","DOI":"10.1080\/19490976.2022.2112881","article-title":"Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells","volume":"14","author":"Yu","year":"2022","journal-title":"Gut Microbes"},{"key":"B41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejca.2020.11.040","article-title":"A review of lifestyle and environment risk factors for pancreatic cancer","volume":"145","author":"Zanini","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.7150\/jca.37445","article-title":"Pancreatic cancer, gut microbiota, and therapeutic efficacy","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"188733","DOI":"10.1016\/j.bbcan.2022.188733","article-title":"The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier","volume":"1877","author":"Zhang","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu14183758","article-title":"Significance of gut microbiota and short-chain fatty acids in heart failure","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1623945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:01:41Z","timestamp":1772452901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1623945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":44,"alternative-id":["10.3389\/fcimb.2026.1623945"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1623945","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"1623945"}}